de CaboRMattsonMP
10.1177/1352458516682105 Summary Keywords multiple sclerosis, disease modifying therapy, cancer, treatment of autoimmune disease, multiple sclerosis drug mechanism, cancer treatment, multiple sclerosis treatment Citation Melamed E and Lee MW (2020) Multiple Sclerosis and Cancer: The Ying-Yang Effect of Disease Modifying Therapies
New England Journal of Medicine, 384 (12), 11131124
In that rulemaking (85 FR 58891), we adopted a policy that required hospitals to report on the Medicare cost report the median payer-specific negotiated charge that the hospital had negotiated with all of its Medicare Advantage Organizations (MAOs), by MS-DRG, effective for cost reporting periods ending on or after January 1, 2021
Orlistat is available in both prescription strength (Xenical) and a lower-dose over-the-counter version (Alli)
[DOI] [PMC free article] [PubMed] [Google Scholar] 71.Chun LJ, Tong MJ, Busuttil RW, Hiatt JR